Autoimmunity through cytokine-induced dendritic cell activation.
about
The heat shock protein 90-CDC37 chaperone complex is required for signaling by types I and II interferonsMicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cellsRole of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skinEvaluation of dendritic cells loaded with apoptotic cancer cells or expressing tumour mRNA as potential cancer vaccines against leukemiaDelayed polarization of mononuclear phagocyte transcriptional program by type I interferon isoformsRegulation of type I interferon responsesRegulation of the lifespan in dendritic cell subsetsTwist mediates suppression of inflammation by type I IFNs and AxlJacques Banchereau, PHD: a conversation with Michael Ramsay, MD, president of Baylor Research InstituteAnti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1Visualizing dendritic cell networks in vivoNonobese diabetic mouse congenic analysis reveals chromosome 11 locus contributing to diabetes susceptibility, macrophage STAT5 dysfunction, and granulocyte-macrophage colony-stimulating factor overproductionIsolation and expression profiling of genes upregulated in the peripheral blood cells of systemic lupus erythematosus patients.Modulation of T cell function by combination of epitope specific and low dose anticytokine therapy controls autoimmune arthritis.Interferon-α is not elevated in idiopathic thrombotic thrombocytopenic purpura patients.Laminin and fibronectin treatment leads to generation of dendritic cells with superior endocytic capacity.Hypermethylation of Interferon Regulatory Factor 8 (IRF8) Confers Risk to Vogt-Koyanagi-Harada DiseaseToll-like receptor 9-induced type I IFN protects mice from experimental colitis.IFN priming is necessary but not sufficient to turn on a migratory dendritic cell program in lupus monocytes.Mediation of nonerosive arthritis in a mouse model of lupus by interferon-alpha-stimulated monocyte differentiation that is nonpermissive of osteoclastogenesis.Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatmentMolecular control of steady-state dendritic cell maturation and immune homeostasis.Type-I IFN signaling suppresses an excessive IFN-gamma response and thus prevents lung damage and chronic inflammation during Pneumocystis (PC) clearance in CD4 T cell-competent mice.Accelerated chemokine receptor 7-mediated dendritic cell migration in Runx3 knockout mice and the spontaneous development of asthma-like diseaseContribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus.Dendritic cells continue to capture and present antigens after maturation in vivo.Interferon-inducible p200-family proteins as novel sensors of cytoplasmic DNA: role in inflammation and autoimmunitySOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling.Toll-like receptor 7 stimulates the expression of Epstein-Barr virus latent membrane protein 1Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9.Expression of ESE-3 isoforms in immunogenic and tolerogenic human monocyte-derived dendritic cells.PD-L2+ dendritic cells and PD-1+ CD4+ T cells in schistosomiasis correlate with morbidity.Stable T cell-dendritic cell interactions precede the development of both tolerance and immunity in vivo.Dendritic cell subsets in health and disease.CD20 antibody primes B lymphocytes for type I interferon production.Involvement of CD226+ NK cells in immunopathogenesis of systemic lupus erythematosusPlasmacytoid dendritic cells and the control of herpesvirus infections.Emerging roles for the interferon-inducible p200-family proteins in sex bias in systemic lupus erythematosus.Evolutionary genetic dissection of human interferons.A medical conundrum: onset of psoriasis in patients receiving anti-tumour necrosis factor agents.
P2860
Q24294462-2F6EF5AB-BFA7-4087-82F5-C271C024A1B2Q24645977-B63257DD-6E86-4482-9F44-F908C72ACC88Q24646247-11679DF9-9798-452A-89CE-4C644452A7C9Q24800882-0FBA55F4-A075-45AD-8917-B49EA0239401Q24814274-50E5498C-F906-4ADF-84FE-8EF306419D00Q26853177-98E68F87-3146-4030-9424-422A14BAE76DQ28505315-005BB2D2-2422-485D-A569-3C12C81CFA48Q28509359-AC1F66C7-D72E-4762-8F4A-80D8E0D82401Q28767051-E72AF2A8-4AB7-423B-A1D5-6F1749C886EFQ28768582-3EE137FC-FA84-4974-A49D-0BB5BF684F4BQ29616233-79071CD7-E081-4012-B107-BD724345E633Q30440604-31EB8F08-7413-4B7A-BA40-8235DE955A7EQ30817633-FBD2FEC7-48F1-4C44-8359-D70440573561Q33267344-DC8A7778-CCE7-4FEB-9EC7-0F1CA889A159Q33414868-A4690F83-BBAB-4A6D-B787-384B6EBDBDD9Q33564191-A7C4B1E1-6B84-4372-9333-DF777390ED23Q33682654-C6EC6A27-BF62-4016-BE53-85AD37D00E58Q33683729-0BA739FF-5E25-457C-A810-B28F13478C42Q33788323-ADDB77A8-76B5-43B1-8555-2382FB49763BQ33790174-05677162-FB2A-44CC-A66D-1E1DEC9DA0B5Q33873657-70305801-41C4-4D7A-8AEB-39F75AD0D4E5Q33882051-8A472B35-AA87-430B-A988-D2F059E20EAFQ33882469-170E0FDE-90CF-4D59-871D-C539CACAD563Q33906792-F562C26C-10B7-4A68-884C-DC0616F14F05Q33933077-A7914396-54FD-42CF-A8B9-5F70CFC8E0A5Q34084191-D157EC80-62DE-4642-A9D7-8CDAAD5D955EQ34163340-1D857A20-1402-45A2-A9B6-6DA8F2F2B2F1Q34211024-5B3672CC-1667-45B4-B54B-C35384D97F7EQ34405076-0B1A4BAA-454C-4473-BF27-6F35ADD5D6AFQ34420799-AF89FACE-DB77-4B30-A272-7946F588F01CQ34490196-1C1337F7-2576-4F32-9B43-2642B30C7E7CQ34556528-E3A8ABA6-89D2-486A-BCDE-5D5A98DA7173Q34558048-87928732-10F7-4F8F-93A6-E3B635055EF1Q34582889-8B1C50BF-82AB-4CD0-9FAA-593E8AA917B4Q34846171-0A57DA19-4A2C-423B-BB73-62A528447851Q34989378-C09B54EC-0777-4C96-95F6-513DF2009834Q35259804-56186832-AEFA-40E4-9425-CFF122796392Q35603591-24C67035-B229-4C47-87E1-99B92F7D1406Q35627683-3BDED0A8-7325-447D-960D-FAB61F93F212Q35638537-8221C9E3-39B1-4086-9517-1AC05B5C04A2
P2860
Autoimmunity through cytokine-induced dendritic cell activation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Autoimmunity through cytokine-induced dendritic cell activation.
@ast
Autoimmunity through cytokine-induced dendritic cell activation.
@en
type
label
Autoimmunity through cytokine-induced dendritic cell activation.
@ast
Autoimmunity through cytokine-induced dendritic cell activation.
@en
prefLabel
Autoimmunity through cytokine-induced dendritic cell activation.
@ast
Autoimmunity through cytokine-induced dendritic cell activation.
@en
P1433
P1476
Autoimmunity through cytokine-induced dendritic cell activation.
@en
P2093
A Karolina Palucka
Virginia Pascual
P304
P356
10.1016/S1074-7613(04)00108-6
P407
P577
2004-05-01T00:00:00Z